Daily Recap: Health — 28 October 2026

Health news today centers on how institutions respond to risk, from calls to treat climate change as a medical emergency to disputes over drug oversight and access. At the same time, new findings sharpen attention on long-term disease burdens, sports-related brain injury and obes...

Doctors and researchers press the World Health Organization and governments to declare climate change a global health emergency. They argue that worsening harm from extreme heat, drought, floods and air pollution is outpacing current mitigation and protection efforts, and that a formal declaration could help speed policy action and public-health planning.

FDA scientists largely oppose a U.S. plan to ease access to certain unproven peptide drugs, reflecting internal resistance to a policy tied to Health Secretary Robert F. Kennedy Jr. The proposal covers some injectable peptides marketed in the wellness sector and raises concerns inside the agency about loosening standards for products without established evidence.

The U.S. Department of Health and Human Services separately moves to temporarily allow some pharmacies to compound and dispense six peptides. Kennedy says the step will remain in place while the department develops a broader regulatory update, creating a near-term shift in access even as debate continues over evidence, safety and federal oversight.

A new population-based study estimates that about 75% of former NFL players who died between 2008 and 2023 had chronic traumatic encephalopathy at death. The research offers a major prevalence estimate for the degenerative brain disease among deceased players, using statistical modeling rather than diagnosis in living people.

India’s patent office rejects a TB Alliance patent application tied to a treatment regimen for drug-resistant tuberculosis. The decision follows objections from patient and civil society groups, who contend the drug combination is already known and should not receive patent protection, a ruling that could affect treatment access and pricing.

Eli Lilly’s experimental obesity drug retatrutide shows promise in easing sleep apnea symptoms in trial results now being reported. In the study, the drug reduces symptoms by more than half in a majority of participants, adding to evidence that weight-loss medicines may also improve serious complications linked to obesity.

Most people in Britain oppose a planned strike by senior NHS doctors, according to a new YouGov poll. The survey finds public sentiment more against than in favor of industrial action next month, giving a political and public backdrop to the latest labor dispute involving England’s health service.

Experts say social media claims that buttock shape can reveal estrogen levels are not supported by medical evidence. Body shape varies for many reasons, and hormone levels cannot be reliably judged by appearance, making laboratory testing the appropriate way to assess estrogen rather than visual cues.